Breast hormonal receptors test should be repeated on excisional biopsy after negative core needle biopsy

Breast Journal

Volumn 17, Issue 2, 2011, Pages 180-186

  Khoury, Thaer ^a   Zakharia, Yousef ^b   Tan, Wei ^a   Kulkarni, Swati ^a   Liu, Weiguo ^a   Zhang, Shanxiang ^a   Wilding, Gregory E ^a   Edge, Stephen ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b Department of Medicine   (United States)

Author keywords

concordance; core needle biopsy; estrogen receptor; excisional biopsy; progesterone receptor

Indexed keywords

ANTIBODY; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; BIOPSY TECHNIQUE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER SIZE; CANCER TISSUE; CARCINOMA; CORE NEEDLE BIOPSY; DISEASE SEVERITY; EXCISIONAL BIOPSY; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; INVASIVE DUCTAL CARCINOMA; INVASIVE LOBULAR CARCINOMA; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; NEEDLE BIOPSY; PATIENT ASSESSMENT; REPEAT PROCEDURE; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; BIOPSY, NEEDLE; BREAST; BREAST NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SENSITIVITY AND SPECIFICITY;

EID: 79952766011     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/j.1524-4741.2010.01051.x     Document Type: Article

References (24)

1. Alberts SR, Ingle JN, Roche PR, et al. Comparison of estrogen receptor determinations by a biochemical ligand binding assay and immunohistochemical staining with monoclonal antibody ER1D5 in females with lymph node positive breast carcinoma entered on two prospective clinical trials. Cancer 1996; 78: 764-72. (Pubitemid 26268606)
2. Barnes DM, Harris WH, Smith P, et al. Immunohistochemical determination of oestrogen receptor: comparison of different methods of assessment of staining and correlation with clinical outcome of breast cancer patients. Br J Cancer 1996; 74: 1445-51. (Pubitemid 26370738)
3. Barnes DM, Millis RR, Beex LV, et al. Increased use of immunohistochemistry for oestrogen receptor measurement in mammary carcinoma: the need for quality assurance. Eur J Cancer 1998; 34: 1677-82. (Pubitemid 28474218)
4. Mann GB, Fahey VD, Feleppa F, et al. Reliance on hormone receptor assays of surgical specimens may compromise outcome in patients with breast cancer. J Clin Oncol 2005; 23: 5148-54. (Pubitemid 46224023)
5. Newsome JF, Avis FP, Hammond JE, et al. Sampling procedures in estrogen receptor determinations. Ann Surg 1981; 193: 549-54. (Pubitemid 11105729)
6. Hasson J, Luhan PA, Kohl MW,. Comparison of estrogen receptor levels in breast cancer samples from mastectomy and frozen section specimens. Cancer 1981; 47: 138-9. (Pubitemid 11167372)
7. Teicher I, Tinker MA, Auguste LJ, et al. Effect of operative devascularization on estrogen and progesterone receptor levels in breast cancer specimens. Surgery 1985; 98: 784-91. (Pubitemid 16164139)
8. Young SC, Burkett RJ, Stewart C,. Discrepancy in ER levels of breast carcinoma in biopsy vs mastectomy specimens. J Surg Oncol 1985; 29: 54-6. (Pubitemid 15032899)
9. Cheang MC, Treaba DO, Speers CH, et al. Immunohistochemical detection using the new rabbit monoclonal antibody sp1 of estrogen receptor in breast cancer is superior to mouse monoclonal antibody 1d5 in predicting survival. J Clin Oncol 2006; 24: 5637-44. (Pubitemid 46631303)
10. Brock JE, Hornick JL, Richardson AL, et al. A comparison of estrogen receptor SP1 and 1D5 monoclonal antibodies in routine clinical use reveals similar staining results. Am J Clin Pathol 2009; 132: 396-401.
11. Harvey JM, Clark GM, Osborne CK, et al. Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol 1999; 17: 1474-81. (Pubitemid 29220854)
12. Clopper CJ, Pearson ES,. The use of confidence or fiducial limits illustrated in the case of the binomial. Biometrika 1934; 26: 404-13.
13. Pepe MS,. The Statistical Evaluation of Medical Tests for Classification and Prediction. New York: Oxford University Press, 2003.
14. Fisher B, Costantino J, Redmond C, et al. A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors. N Engl J Med 1989; 320: 479-84. (Pubitemid 19062522)
15. Allred DC, Bustamante MA, Daniel CO, et al. Immunocytochemical analysis of estrogen receptors in human breast carcinomas. Arch Surg 1990; 125: 107-13.
16. Allred DC, Harvey JM, Berardo M, et al. Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol 1998; 11: 155-68. (Pubitemid 28144151)
17. Khoury T, Sait S, Hwang H, et al. Delay to formalin fixation effect on breast biomarkers. Mod Pathol 2009; 22: 1457-67.
18. Goldstein NS, Ferkowicz M, Odish E, et al. Minimum formalin fixation time for consistent estrogen receptor immunohistochemical staining of invasive breast carcinoma. Am J Clin Pathol 2003; 120: 86-92. (Pubitemid 37046374)
19. Oyama T, Ishikawa Y, Hayashi M, et al. The effects of fixation, processing and evaluation criteria on immunohistochemical detection of hormone receptors in breast cancer. Breast Cancer 2007; 14: 182-8.
20. Zidan A, Christie Brown JS, Peston D, et al. Oestrogen and progesterone receptor assessment in core biopsy specimens of breast carcinoma. J Clin Pathol 1997; 50: 27-9. (Pubitemid 27060200)
21. Railo M, Nordling S, Krogerus L, et al. Preoperative assessment of proliferation activity and hormonal receptor status in carcinoma of the breast: a comparison of needle aspiration and needle-core biopsies to the surgical specimen. Diagn Cytopathol 1996; 15: 205-10. (Pubitemid 26404635)
22. Jacobs TW, Sizipikou KP, Prioleau JE, et al. Do prognostic marker studies on core needle biopsy specimens of breast carcinoma accurately reflect the marker status of the tumor? Mod Pathol 1998; 11: 259-64. (Pubitemid 28131535)
23. Fentiman IS, Millis RR, Chaudary MA, et al. Effect of the method of biopsy on the prognosis of and reliability of receptor assays in patients with operable breast cancer. Br J Surg 1986; 73: 610-2. (Pubitemid 16039354)
24. Connor CS, Tawfik OW, Joyce AJ, et al. A comparison of prognostic tumor markers obtained on image-guided breast biopsies and final surgical specimens. Am J Surg 2002; 184: 322-4. (Pubitemid 35287351)